Dyax Overview

  • Founded
  • 1995
  • Status
  • Acquired/​Merged
  • Employees
  • 203
  • Latest Deal Type
  • M&A
  • Latest Deal Amount
  • $6.5B
Latest Deal Amount

Dyax General Information


Developer of biopharmaceuticals for oncology and inflammatory indications. The company offers drug discovery technology, known as phage display to identify antibody, small protein and peptide compounds for clinical development and provides chromatography separations systems and products that are used in laboratories and pharmaceutical manufacturing to separate molecules in liquid mixtures.

Contact Information

Ownership Status
Financing Status
Formerly VC-backed
Primary Industry
Discovery Tools (Healthcare)
Other Industries
Drug Discovery
Primary Office
  • 55 Network Drive
  • Burlington, MA 01803
  • United States
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Dyax Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
12. Merger/Acquisition 22-Jan-2016 $6.5B 00000 00.00 Completed Generating Revenue
11. PIPE 02-Nov-2015 00000 Completed Generating Revenue
10. PIPE 13-May-2013 0000 00000 Completed Generating Revenue
9. PIPE 01-Jan-2012 00000 Completed Generating Revenue
8. PIPE 01-Jan-2009 00000 Completed Generating Revenue
7. PIPE 01-Oct-2008 0000 00000 Completed Generating Revenue
6. PIPE 01-Aug-2006 000.00 Completed Generating Revenue
5. PIPE 14-Mar-2003 00.000 000.00 Completed Generating Revenue
4. IPO 15-Aug-2000 $60M $44.5M 00000 Completed Generating Revenue
3. Later Stage VC 16-Nov-1998 $31M $44.5M Completed Startup
To view Dyax’s complete valuation and funding history, request access »

Dyax Signals

Growth Rate

0.80% Weekly
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers


Similarweb Unique Visitors


Majestic Referring Domains


PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Dyax Former Investors (27)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Alta Partners Venture Capital Minority 000 0000 000000 0
Baker Bros. Advisors Limited Partner Minority 000 0000 000000 0
BancBoston Capital PE/Buyout Minority 000 0000 000000 0
BancBoston Ventures Venture Capital Minority 000 0000 000000 0
Federated Investors and Affiliates Corporation Minority 000 0000 000000 0
You’re viewing 5 of 27 investors. Get the full list »